FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Christian Club Files Lawsuit After School District Blocks Volunteer Mentors

African Witchcraft, Blackmail, and American Boys: How Nigerians 6,000 Miles Away Are Killing US Teens

Mixed support from black voters threatens el Sayed’s Michigan Senate hopes

Trump plays nuclear poker with Kim Jong Un — but who holds the cards?

DOJ silence in major gun cases tests Second Amendment advocates’ trust in Trump

Fetterman aligns with Trump on AI push, warns China benefits from US ‘overreaction’

Bear crashes couple’s anniversary getaway, rummages through Tennessee tea shop before jumping on counter

Police make arrest after gunfire during California high school football game leaves 1 dead

Connecticut police officers shot, suspect killed after attempted arrest sparks hectic chase

‘Will Come Back to Bite You’: Top Official Asked Fauci for Vaccine Side Effect Study – Email

Breaking: Judge Slaps Down Karmelo Anthony’s Bid for New Trial

Nancy Kassebaum Baker, trailblazing GOP senator who broke barriers for women in Congress, dead at 94

Judge denies Karmelo Anthony’s bid for new trial after ex-lawyers detail dispute that kept him from testifying

Judge denies Karmelo Anthony new-trial bid after ex-lawyers detail dispute that kept him from testifying

Federal judge blasts Rubio’s 75-country visa freeze as ‘Orwellian,’ strikes down policy

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”